Pedersini, Rebecca
 Distribuzione geografica
Continente #
NA - Nord America 669
EU - Europa 427
AS - Asia 269
SA - Sud America 3
OC - Oceania 2
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.372
Nazione #
US - Stati Uniti d'America 662
DE - Germania 113
IT - Italia 103
SG - Singapore 102
CN - Cina 87
UA - Ucraina 46
FI - Finlandia 43
RU - Federazione Russa 42
HK - Hong Kong 35
TR - Turchia 24
CZ - Repubblica Ceca 23
GB - Regno Unito 22
IE - Irlanda 13
ID - Indonesia 10
IN - India 9
CH - Svizzera 7
CA - Canada 6
FR - Francia 6
AR - Argentina 2
AU - Australia 2
BE - Belgio 2
RO - Romania 2
BY - Bielorussia 1
CR - Costa Rica 1
EU - Europa 1
FK - Isole Falkland (Malvinas) 1
HU - Ungheria 1
IM - Isola di Man 1
JO - Giordania 1
MU - Mauritius 1
NL - Olanda 1
PH - Filippine 1
PL - Polonia 1
Totale 1.372
Città #
Fairfield 104
Singapore 92
Woodbridge 67
Chandler 43
Ashburn 41
New York 38
Seattle 38
Cambridge 36
Hong Kong 35
Jacksonville 35
Helsinki 34
Houston 33
Wilmington 33
Istanbul 23
Beijing 22
Boardman 21
Princeton 20
Ann Arbor 16
Brno 15
Brescia 14
Dalmine 13
Dublin 13
Moscow 13
Munich 12
Jakarta 10
Los Angeles 9
Milan 9
Nanjing 8
Romola 8
Shanghai 8
Olomouc 7
Dearborn 6
Mumbai 6
Nanchang 6
Nürnberg 6
Changsha 5
Des Moines 5
Dietikon 5
Jinan 5
London 5
Perugia 5
Naples 4
San Diego 4
Genoa 3
Jiaxing 3
Lappeenranta 3
Ottawa 3
Rome 3
Toronto 3
Bergamo 2
Buenos Aires 2
Canberra 2
Cornuda 2
Giussano 2
Lancaster 2
Leipzig 2
Melfi 2
Orange 2
Pianello del Lario 2
Poli 2
S. Pietro 2
Shenyang 2
Turin 2
Altoona 1
Amman 1
Belluno 1
Brussels 1
Calcinato 1
Clifton 1
Delhi 1
Douglas 1
Espoo 1
Galati 1
Gunzenhausen 1
Hangzhou 1
Hefei 1
Hyderabad 1
Kocaeli 1
Lanzhou 1
Ma'anshan 1
Magdeburg 1
Mariano Comense 1
Menen 1
Mogilëv 1
Nanning 1
Nave 1
Ningbo 1
Nuremberg 1
Pasig 1
Prague 1
San Francisco 1
San José 1
Tianjin 1
Warsaw 1
Washington 1
Wuxi 1
Zhengzhou 1
Totale 1.012
Nome #
Should Adjuvant Weekly Paclitaxel Be Considered Less Efficacious Than Anthracyclines Plus Cyclophosphamide for Lower Risk Patients With Early-Stage Breast Cancer? 138
Morphometric vertebral fractures in breast cancer patients treated with adjuvant aromatase inhibitor therapy: A cross-sectional study 130
Adjuvant bisphosphonates in patients with breast cancer: Does the potency matter? 129
Pathologic Complete Response As a Potential Surrogate for the Clinical Outcome in Patients With Breast Cancer After Neoadjuvant Therapy: A Meta-Regression of 29 Randomized Prospective Studies. 129
Eribulin Treatment in Patients with Liver Metastatic Breast Cancer: Eight Italian Case Reports 119
Leptomeningeal metastasis from solid tumors: a diagnostic and therapeutic challenge. 111
Eribulin in Heavily Pretreated Metastatic Breast Cancer Patients in the Real World: A Retrospective Study 95
Sacituzumab govitecan and radiotherapy in metastatic, triple-negative, and BRCA-mutant breast cancer patient with active brain metastases: A case report 69
Ovarian Strumal Carcinoid: Case Report, Systematic Literature Review and Pooled Analysis 42
Taste Alterations Do Not Affect Change in Food Habits and Body Weight in Breast Cancer Patients 37
Progression of vertebral fractures in patients with adrenocortical carcinoma undergoing mitotane therapy 36
Assessment of DXA derived bone quality indexes and bone geometry parameters in early breast cancer patients: A single center cross-sectional study 35
Taste alterations during neo/adjuvant chemotherapy and subsequent follow-up in breast cancer patients: a prospective single-center clinical study 35
Real-World Effectiveness of Denosumab and Bisphosphonates on Risk of Vertebral Fractures in Women with Breast Cancer Undergoing Treatment with Aromatase Inhibitors 33
Is weight gain preventable in women with early breast cancer undergoing chemotherapy? A real-world study on dietary pattern, physical activity, and body weight before and after chemotherapy 31
Sleep disturbances and restless legs syndrome in postmenopausal women with early breast cancer given adjuvant aromatase inhibitor therapy 30
Prediction of vertebral fractures in cancer patients undergoing hormone deprivation therapies: Reliability of who fracture risk assessment tool (frax) and bone mineral density in real-life clinical practice 28
Denosumab improves trabecular bone score in relationship with decrease in fracture risk of women exposed to aromatase inhibitors 27
Gastrointestinal Toxicity of Antibody Drug Conjugates (ADCs) in Metastatic Breast Cancer: A Pooled Analysis 23
Fat Body Mass and Vertebral Fracture Progression in Women With Breast Cancer 23
Immune-related adverse events as potential surrogates of immune checkpoint inhibitors’ efficacy: a systematic review and meta-analysis of randomized studies 23
Correction: Denosumab improves trabecular bone score in relationship with decrease in fracture risk of women exposed to aromatase inhibitors 22
Role of Body Composition in the Prediction of Skeletal Fragility Induced by Hormone Deprivation Therapies in Cancer Patients 21
Changes in body composition in early breast cancer patients treated with aromatase inhibitors 16
Body composition in early breast cancer patients treated with adjuvant aromatase inhibitors: Does dietary counseling matter? 13
Bone-active drugs in premenopausal women with breast cancer under hormone-deprivation therapies 11
Adjuvant denosumab for early breast cancer-Evidence and controversy 7
Totale 1.413
Categoria #
all - tutte 9.735
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.735


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020124 0 0 0 0 0 0 24 25 24 32 5 14
2020/2021114 2 17 0 20 1 11 12 10 13 13 13 2
2021/202273 6 1 5 2 0 3 2 6 2 12 6 28
2022/2023133 11 2 3 9 12 34 0 12 17 11 17 5
2023/2024301 18 7 26 18 19 48 10 9 48 11 7 80
2024/2025294 22 10 12 143 63 44 0 0 0 0 0 0
Totale 1.413